HT
HZNP

HAP Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HAP Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,475
Closed -$835K – 2234
2022
Q2 		$835K Buy
+10,475
New +$992K 0.04% 333
2021
Q2 		– Sell
-23,562
Closed -$2.17M – 2786
2021
Q1 		$2.17M Sell
23,562
-95,055
-80% -$8.02M 0.12% 166
2020
Q4 		$8.68M Buy
+118,617
New +$8.82M 0.25% 64
2018
Q1 		– Sell
-52,873
Closed -$781K – 1281
2017
Q4 		$772K Buy
+52,873
New +$743K 0.03% 317
2017
Q1 		– Sell
-50,440
Closed -$817K – 1360
2016
Q4 		$816K Sell
50,440
-123,720
-71% -$2.24M 0.04% 280
2016
Q3 		$3.16M Buy
+174,160
New +$3.4M 0.11% 107
2016
Q2 		– Sell
-22,421
Closed -$363K – 1102
2016
Q1 		$372K Sell
22,421
-50,743
-69% -$888K 0.03% 328
2015
Q4 		$1.58M Sell
73,164
-42,381
-37% -$825K 0.08% 210
2015
Q3 		$2.29M Sell
115,545
-36,611
-24% -$1.16M 0.12% 169
2015
Q2 		$5.29M Buy
152,156
+26,400
+21% +$806K 0.32% 73
2015
Q1 		$3.27M Buy
+125,756
New +$2.31M 0.22% 102
2014
Q3 		– Sell
-96,011
Closed -$1.52M – 1249
2014
Q2 		$1.52M Buy
96,011
+6,885
+8% +$98.3K 0.06% 250
2014
Q1 		$1.35M Buy
+89,126
New +$1.01M 0.06% 269

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HAP Trading's HZNP Position: Q3 2022 in Review

HAP Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 10,475 shares — an estimated $835K sold.

HAP Trading first reported a position in HZNP in Q1 2014 and held it in 13 quarters. The position peaked at $8.68M in Q4 2020. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • HAP Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • HAP Trading sold 10,475 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $835K.
  • HAP Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 13 quarters.
  • HAP Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.68M in Q4 2020.
  • 529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on HAP Trading's 13F filing for Q3 2022, filed 14 Nov 2022.